Parietal alpha asymmetry as a diagnostic marker for depression and a predictive biomarker for anhedonia improvement after melatonergic antidepressant treatment
Journal of Affective Disorders · 2026
DOI: 10.1016/j.jad.2025.120977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Ching-En Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei Tzu Chi Hospital, Taipei, Taiwan; Tzu Chi University, Hualien, Taiwan. Hauptthemen laut MEDLINE: Anhedonia, Major Depressive Disorder, Alpha Rhythm, Antidepressive Agents. Die Arbeit nennt 67 Literaturangaben. Gefördert von: Taipei Tzu Chi Hospital, Ministry of National Defense Medical Affairs Bureau, Ministry of National Defense.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Major depressive disorder (MDD) is often marked by anhedonia, a symptom poorly addressed by first-line antidepressants. While frontal alpha asymmetry (FAA) has been widely studied, findings are inconsistent. Recent evidence suggests parietal alpha asymmetry (PAA) may better capture reward-related dysfunction. METHODS: We examined resting-state EEG alpha asymmetry in 84 unmedicated MDD patients and 143 healthy controls (HCs). Patients received 8 weeks of agomelatine, a melatonergic antidepressant. Anhedonia was assessed with the Snaith-Hamilton Pleasure Scale (SHAPS) and the 5-item anhedonia subscale of the Montgomery-Åsberg Depression Rating Scale (MADRS). RESULTS: At baseline, MDD patients showed reduced PAA, especially at P7-P8, distinguishing them from HCs (AUC = 0.85). After treatment, depressive symptoms, anxiety, cognition, and anhedonia improved significantly. Lower baseline P3-P4 asymmetry predicted greater improvement in clinician-rated anhedonia, whereas FAA showed no predictive value. Sex-stratified analyses indicated F3-F4 abnormalities were specific to females, while P7-P8 changes were robust across sexes. CONCLUSIONS: PAA, particularly at P7-P8, demonstrated diagnostic utility, while P3-P4 asymmetry was associated with treatment-related improvement in anhedonia. This study extends prior work by including a larger unmedicated MDD cohort, focusing on melatonergic treatment, and employing subitem-level anhedonia measures. Findings support PAA as a state-sensitive biomarker for diagnostic classification and prognosis in MDD, warranting replication and mechanistic investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, Taipei Tzu Chi Hospital, Taipei, Taiwan; Tzu Chi University, Hualien, Taiwan.
- Graduate Institute of Medical Sciences, National Defense Medical University, Taipei, Taiwan; Taoyuan Psychiatric Center, Ministry of Health and Welfare, Taoyuan, Taiwan.
- Department of Radiology, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
- Department of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (…
- Department of Psychiatry, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan. Electronic address: changcc@mail.ndmctsgh.edu.tw.
- Department of Psychiatry, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan; Non-Invasive Neuromodulation Consortium for Mental Disorders, Society of Psychophysiology, Taipei, Taiwan. Ele…
Förderung
- Taipei Tzu Chi Hospital
- Ministry of National Defense Medical Affairs Bureau
- Ministry of National Defense
- Ministry of Health and Welfare
- National Science and Technology Council
- Tri-Service General Hospital
- Servier
Zitieren
APA
Lin, C. E., Chen, L. F., Chang, W. C., Sack, A. T., Chang, C. C., & Chang, H. A. (2026). Parietal alpha asymmetry as a diagnostic marker for depression and a predictive biomarker for anhedonia improvement after melatonergic antidepressant treatment. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2025.120977
Vancouver
Lin CE, Chen LF, Chang WC, Sack AT, Chang CC, Chang HA. Parietal alpha asymmetry as a diagnostic marker for depression and a predictive biomarker for anhedonia improvement after melatonergic antidepressant treatment. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2025.120977
BibTeX
@article{Lin2026,
author = {Lin, Ching-En and Chen, Li-Fen and Chang, Wei-Chou and Sack, Alexander T and Chang, Chuan-Chia and Chang, Hsin-An},
title = {Parietal alpha asymmetry as a diagnostic marker for depression and a predictive biomarker for anhedonia improvement after melatonergic antidepressant treatment},
journal = {Journal of Affective Disorders},
year = {2026},
doi = {10.1016/j.jad.2025.120977}
}
EUVIMED